27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended holding Biomarin Pharmaceutical Inc (NASDAQ: BMRN).
When asked about Black Stone Minerals LP (NYSE:BSM), he said, "I like this situation."
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Don’t forget to check out our premarket coverage here.
"That’s it, one of these personalized oncology companies. Here’s what I say about those. Some of them are going to work, and some are not," Cramer said, when asked about Kura Oncology Inc (NASDAQ:KURA).
Price Action: Shares of BioMarin Pharmaceutical dropped 0.1% to close at $111.15, while Black Stone Minerals fell 1.5% to settle at $15.71 on Wednesday. Kura Oncology shares gained 4.4% to close at $12.47 during the session.
Now Read This: Investor Optimism Improves Ahead Of Key Inflation Data
Photo via Shutterstock.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.